A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

Related: The FDA Is Investigating Reports of These Serious Side Effects from Weight Loss Drugs NAION is a rare eye condition that mainly affects people over the age of 50. The main symptom of ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

A RETROSPECTIVE case series has identified ophthalmic complications in patients using the antidiabetic drugs semaglutide and ...

Get Instant Summarized Text (Gist) Once-weekly semaglutide use in individuals with type 2 diabetes more than doubles the risk of developing nonarteritic anterior ischemic optic neuropathy (NAION ...

In the American study, it was observed that Ozempic more than doubles the risk of the rare condition NAION (non-arteritic anterior ischemic optic neuropathy), which causes damage to the optic ...

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...

Two large studies from the University of Southern Denmark suggest that the diabetes medication Ozempic doubles the risk of developing NAION, a rare but serious condition that damages the optic nerve.